How many insider trades does FilingIQ track for CRBU?

FilingIQ tracks 82 Form 4 insider transactions for CRBU (Caribou Biosciences, Inc.), covering filings from Jul 27, 2021 onwards. 24 of those were filed in the last 90 days.

Are CRBU insiders net buyers or net sellers?

Across the full Form 4 history for CRBU, 13 transactions (16%) were open-market purchases and 11 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CRBU insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CRBU in?

Caribou Biosciences, Inc. (CRBU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $201.89M.

CRBU insider trading

NasdaqGS Healthcare

Caribou Biosciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

16% / 13%

Market cap

$201.89M

About Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Company website: cariboubio.com

CRBU insider activity at a glance

FilingIQ has scored 82 insider transactions for CRBU since Jul 27, 2021. The most recent filing in our index is dated Feb 25, 2026.

Across the full history, 13 open-market purchases and 11 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CRBU insider trades is 55.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CRBU trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading CRBU

JOHNSON DAVID LEE

4 trades · score 69.0

Frequently asked

How many insider trades does FilingIQ track for CRBU?: FilingIQ tracks 82 Form 4 insider transactions for CRBU (Caribou Biosciences, Inc.), covering filings from Jul 27, 2021 onwards. 24 of those were filed in the last 90 days.
Are CRBU insiders net buyers or net sellers?: Across the full Form 4 history for CRBU, 13 transactions (16%) were open-market purchases and 11 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CRBU insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CRBU in?: Caribou Biosciences, Inc. (CRBU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $201.89M.

Methodology & sources

Every CRBU insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.